Skip to content
Home/Companies/Biotech/Modus Therapeutics
Modus Therapeutics

Modus Therapeutics

Biotech·Sweden·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Modus Therapeutics?

Modus Therapeutics is currently owned by HealthCap through HealthCap VII (2016 vintage), since 2018. Across its history, Modus Therapeutics has been through 3 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-16

HealthCap
Most recent investor
HealthCap
HealthCap VII · 2016 · VC
3 ownership periods · full history below

Key facts

HQSweden
SectorBiotech
StatusAcquired

Ownership history

3 ownership periods · co-invest detected

Active
Co-held by Karolinska Development and HealthCap since 2011.
Co-invest · 3 holders · 2011 · present
Karolinska Development
2011 · present(15yr) · Karolinska Development · 2003 · Life Sciences VC
Rosetta Capital
Rosetta CapitalExited 2021
2013 · 2021(8yr) · Rosetta Capital IV · 2013 · Secondaries
IPO
MOIC
–
HealthCap
HealthCapActive
2018 · present(8yr) · HealthCap VII · 2016 · VC
Track Modus Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Modus Therapeutics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Modus Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue